Velan Capital Investment Management Lp Top Holdings and 13F Report (2024) About Velan Capital Investment Management LpInvestment ActivityVelan Capital Investment Management Lp has $106.94 million in total holdings as of September 30, 2024.Velan Capital Investment Management Lp owns shares of 18 different stocks, but just 6 companies or ETFs make up 80% of its holdings.Approximately 21.86% of the portfolio was purchased this quarter.About 76.16% of the portfolio was sold this quarter.This quarter, Velan Capital Investment Management Lp has purchased 17 new stocks and bought additional shares in 3 stocks.Velan Capital Investment Management Lp sold shares of 3 stocks and completely divested from 5 stocks this quarter.Largest Holdings JASPER THERAPEUTICS INC $26,970,305PRAXIS PRECISION MEDICINES I $20,177,322SPDR S&P Biotech ETF $14,820,000Heron Therapeutics $13,903,621TOURMALINE BIO INC $8,514,895 Largest New Holdings this Quarter SPDR S&P Biotech ETF $14,820,000 HoldingLiquidia $3,000,000 HoldingscPharmaceuticals $2,360,566 HoldingZevra Therapeutics $1,388,000 HoldingCorbus Pharmaceuticals $1,031,500 Holding Largest Purchases this Quarter SPDR S&P Biotech ETF 150,000 shares (about $14.82M)Liquidia 300,000 shares (about $3M)scPharmaceuticals 517,668 shares (about $2.36M)Zevra Therapeutics 200,000 shares (about $1.39M)Corbus Pharmaceuticals 50,000 shares (about $1.03M) Largest Sales this Quarter SKYE BIOSCIENCE INC 211,071 shares (about $825.29K)JASPER THERAPEUTICS INC 38,076 shares (about $716.21K)OptiNose 346,222 shares (about $231.97K) Sector Allocation Over TimeMap of 500 Largest Holdings ofVelan Capital Investment Management Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorJASPER THERAPEUTICS INC$26,970,305$716,210 ▼-2.6%1,433,82825.2%COM NEWPRAXIS PRECISION MEDICINES I$20,177,3220.0%350,66618.9%COM NEWXBISPDR S&P Biotech ETF$14,820,000$14,820,000 ▲New Holding150,00013.9%ETFHRTXHeron Therapeutics$13,903,6210.0%6,986,74413.0%MedicalTOURMALINE BIO INC$8,514,895$311,348 ▲3.8%331,1908.0%COMRZLTRezolute$3,880,0000.0%800,0003.6%MedicalLQDALiquidia$3,000,000$3,000,000 ▲New Holding300,0002.8%MedicalCNTXContext Therapeutics$2,529,0330.0%1,290,3232.4%MedicalNSPRInspireMD$2,422,7980.0%904,0292.3%MedicalSCPHscPharmaceuticals$2,360,566$2,360,566 ▲New Holding517,6682.2%MedicalTELATELA Bio$1,890,947$3,347 ▲0.2%747,4101.8%MedicalOPTNOptiNose$1,438,227$231,969 ▼-13.9%2,146,6081.3%MedicalZVRAZevra Therapeutics$1,388,000$1,388,000 ▲New Holding200,0001.3%MedicalTARAProtara Therapeutics$1,050,420$172,020 ▲19.6%574,0001.0%MedicalCRBPCorbus Pharmaceuticals$1,031,500$1,031,500 ▲New Holding50,0001.0%MedicalSKYE BIOSCIENCE INC$825,288$825,288 ▼-50.0%211,0710.8%COM NEWKIORA PHARMACEUTICALS INC$447,3360.0%122,2230.4%COMTENAX THERAPEUTICS INC$288,332$288,332 ▲New Holding83,3330.3%COM NEWALIMAlimera Sciences$0$75,663,443 ▼-100.0%00.0%MedicalOUTLOOK THERAPEUTICS INC$0$1,823,480 ▼-100.0%00.0%COMELEVElevation Oncology$0$1,612,707 ▼-100.0%00.0%MedicalXFORX4 Pharmaceuticals$0$382,232 ▼-100.0%00.0%MedicalASLNASLAN Pharmaceuticals$0$187,500 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
